• News
  • Signs of progress by pharma against superbugs...
News - published on 18 Nov 2021

Signs of progress by pharma against superbugs, yet little movement to address access

Pharma companies press on in fight against superbugs despite COVID-19 pandemic, finds the 2021 Antimicrobial Resistance Benchmark. But action to improve global access to antibiotics still lags. The Benchmark tracks 17 of the world’s largest pharmaceutical companies in the fight against drug resistance.

Explore further

Get in touch

Back to top |